Reply from Authors re: Emmanuel S. Antonarakis, Howard I. Scher. Do Patients With AR-V7-Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4-6: Unsplicing a Conflict

Eur Urol. 2017 Jan;71(1):6-7. doi: 10.1016/j.eururo.2016.08.071. Epub 2016 Sep 15.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms*

Substances

  • Prostate-Specific Antigen